Rajesh C. Shrotriya

2012

In 2012, Rajesh C. Shrotriya earned a total compensation of $10.1M as Chairman, Chief Executive Officer and President at Spectrum Pharmaceuticals, a 60% decrease compared to previous year.

Compensation breakdown

Bonus$1,600,000
Option Awards$5,535,358
Salary$800,000
Stock Awards$1,849,996
Other$322,955
Total$10,108,309

Shrotriya received $5.5M in option awards, accounting for 55% of the total pay in 2012.

Shrotriya also received $1.6M in bonus, $800K in salary, $1.8M in stock awards and $323K in other compensation.

Rankings

In 2012, Rajesh C. Shrotriya's compensation ranked 417th out of 11,487 executives tracked by ExecPay. In other words, Shrotriya earned more than 96.4% of executives.

ClassificationRankingPercentile
All
417
out of 11,487
96th
Division
Manufacturing
154
out of 4,253
96th
Major group
Chemicals And Allied Products
31
out of 1,203
97th
Industry group
Drugs
18
out of 925
98th
Industry
Pharmaceutical Preparations
15
out of 700
98th
Source: SEC filing on April 29, 2014.

Shrotriya's colleagues

We found three more compensation records of executives who worked with Rajesh C. Shrotriya at Spectrum Pharmaceuticals in 2012.

2012

Joseph Keller

Spectrum Pharmaceuticals

Chief Operating Officer

2012

Joseph Turgeon

Spectrum Pharmaceuticals

Chief Operating Officer

2012

Brett Scott

Spectrum Pharmaceuticals

Senior Vice President, Finance

In-depth

You may also like